Xtant Medical Holdings, Inc. (XTNT)
USD 0.36
(-2.07%)
USD 0.36
(-2.07%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.98 Million USD | -28.57% |
| 2022 | -5.42 Million USD | -115.38% |
| 2021 | -2.51 Million USD | -289.91% |
| 2020 | 1.32 Million USD | 68.31% |
| 2019 | 850 Thousand USD | 198.5% |
| 2018 | -54.21 Million USD | 84.98% |
| 2017 | -29.31 Million USD | -814.89% |
| 2016 | 61.43 Thousand USD | 118.76% |
| 2015 | -7.08 Million USD | 15.74% |
| 2014 | -3.89 Million USD | 39.57% |
| 2013 | -7.28 Million USD | -21.52% |
| 2012 | -5.06 Million USD | -12.84% |
| 2011 | -1.08 Million USD | 28.19% |
| 2010 | -17.13 Million USD | -173.1% |
| 2009 | -2.9 Million USD | -18226.8% |
| 2008 | -15.84 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.46 Million USD | -31.78% |
| 2024 Q2 | -1.94 Million USD | 26.36% |
| 2023 Q3 | -3.38 Million USD | -475.68% |
| 2023 Q1 | -1.01 Million USD | 39.81% |
| 2023 Q2 | -588 Thousand USD | 42.3% |
| 2023 FY | - USD | -28.57% |
| 2023 Q4 | -2.78 Million USD | 17.61% |
| 2022 Q3 | -1.52 Million USD | -55.6% |
| 2022 Q4 | -1.69 Million USD | -10.8% |
| 2022 Q1 | -1.55 Million USD | 18.98% |
| 2022 FY | - USD | -115.38% |
| 2022 Q2 | -982 Thousand USD | 36.65% |
| 2021 Q2 | -135 Thousand USD | -136.49% |
| 2021 FY | - USD | -289.91% |
| 2021 Q1 | 370 Thousand USD | 54.17% |
| 2021 Q3 | -1.13 Million USD | -740.74% |
| 2021 Q4 | -1.91 Million USD | -68.55% |
| 2020 Q2 | -387 Thousand USD | 43.42% |
| 2020 FY | - USD | 68.31% |
| 2020 Q3 | 1.26 Million USD | 426.87% |
| 2020 Q4 | 240 Thousand USD | -81.03% |
| 2020 Q1 | -684 Thousand USD | -240.45% |
| 2019 Q2 | 163 Thousand USD | 393.94% |
| 2019 Q3 | 104 Thousand USD | -36.2% |
| 2019 FY | - USD | 198.5% |
| 2019 Q4 | 487 Thousand USD | 368.27% |
| 2019 Q1 | 33 Thousand USD | 100.82% |
| 2018 FY | - USD | 84.98% |
| 2018 Q4 | -4.03 Million USD | -396.55% |
| 2018 Q3 | 1.36 Million USD | 103.44% |
| 2018 Q1 | 649 Thousand USD | 486.46% |
| 2018 Q2 | 669 Thousand USD | 3.08% |
| 2017 Q2 | -4.01 Million USD | -1217.03% |
| 2017 FY | - USD | -814.89% |
| 2017 Q4 | -167.93 Thousand USD | 73.42% |
| 2017 Q3 | -631.74 Thousand USD | 84.25% |
| 2017 Q1 | 359.14 Thousand USD | -42.37% |
| 2016 FY | - USD | 118.76% |
| 2016 Q4 | 623.15 Thousand USD | 34.12% |
| 2016 Q3 | 464.63 Thousand USD | 261.01% |
| 2016 Q2 | -288.57 Thousand USD | 59.12% |
| 2016 Q1 | -705.82 Thousand USD | -1119.25% |
| 2015 Q3 | -1.68 Million USD | -31.21% |
| 2015 Q4 | 69.25 Thousand USD | 104.1% |
| 2015 FY | - USD | 15.74% |
| 2015 Q1 | -1.48 Million USD | 6.44% |
| 2015 Q2 | -1.28 Million USD | 13.4% |
| 2014 Q2 | -1.15 Million USD | 11.6% |
| 2014 FY | - USD | 39.57% |
| 2014 Q4 | -1.58 Million USD | -35.96% |
| 2014 Q3 | -1.16 Million USD | -1.34% |
| 2014 Q1 | -1.3 Million USD | 53.01% |
| 2013 Q4 | -2.77 Million USD | -29.77% |
| 2013 FY | - USD | -21.52% |
| 2013 Q2 | -1.66 Million USD | -60.37% |
| 2013 Q1 | -1.04 Million USD | 81.41% |
| 2013 Q3 | -2.13 Million USD | -28.16% |
| 2012 FY | - USD | -12.84% |
| 2012 Q2 | -157.64 Thousand USD | 85.12% |
| 2012 Q1 | -1.05 Million USD | 56.72% |
| 2012 Q4 | -5.59 Million USD | -289.29% |
| 2012 Q3 | -1.43 Million USD | -811.77% |
| 2011 Q1 | -1.64 Million USD | 57.04% |
| 2011 FY | - USD | 28.19% |
| 2011 Q2 | 18.63 Thousand USD | 101.13% |
| 2011 Q3 | -1.35 Million USD | -7358.58% |
| 2011 Q4 | -2.44 Million USD | -81.04% |
| 2010 Q2 | -1.12 Million USD | -12096.3% |
| 2010 Q1 | -9228.00 USD | -8.23% |
| 2010 Q3 | -1.91 Million USD | -70.59% |
| 2010 FY | - USD | -173.1% |
| 2010 Q4 | -3.82 Million USD | -99.43% |
| 2009 Q4 | -8526.00 USD | -243.44% |
| 2009 Q3 | 5944.00 USD | 101.49% |
| 2009 FY | - USD | -18226.8% |
| 2009 Q2 | -398.06 Thousand USD | -3976.0% |
| 2009 Q1 | -9766.00 USD | 82.03% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | 21.94 Thousand USD | 0.0% |
| 2008 Q4 | -54.35 Thousand USD | -347.7% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Electromed, Inc. | 7.42 Million USD | 194.099% |
| Myomo, Inc. | -8.06 Million USD | 13.428% |
| Senseonics Holdings, Inc. | -48 Million USD | 85.452% |
| Catheter Precision, Inc. | -15.11 Million USD | 53.779% |